These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8891430)

  • 1. New applications of bacterial systems to problems in toxicology.
    Guengerich FP; Gillam EM; Shimada T
    Crit Rev Toxicol; 1996 Sep; 26(5):551-83. PubMed ID: 8891430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cytochrome P450 3A7 in Escherichia coli: effects of 5' modification and catalytic characterization of recombinant enzyme expressed in bicistronic format with NADPH-cytochrome P450 reductase.
    Gillam EM; Wunsch RM; Ueng YF; Shimada T; Reilly PE; Kamataki T; Guengerich FP
    Arch Biochem Biophys; 1997 Oct; 346(1):81-90. PubMed ID: 9328287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexpression of mammalian cytochrome P450 and reductase in Escherichia coli.
    Dong J; Porter TD
    Arch Biochem Biophys; 1996 Mar; 327(2):254-9. PubMed ID: 8619611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioactivation of aromatic amines by recombinant human cytochrome P4501A2 expressed in Ames tester strain bacteria: a substitute for activation by mammalian tissue preparations.
    Josephy PD; DeBruin LS; Lord HL; Oak JN; Evans DH; Guo Z; Dong MS; Guengerich FP
    Cancer Res; 1995 Feb; 55(4):799-802. PubMed ID: 7850792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of retained N-formylmethionine in bacterial recombinant mammalian cytochrome P450 proteins with the N-terminal sequence MALLLAVFL...: roles of residues 3-5 in retention and membrane topology.
    Dong MS; Bell LC; Guo Z; Phillips DR; Blair IA; Guengerich FP
    Biochemistry; 1996 Aug; 35(31):10031-40. PubMed ID: 8756465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase.
    Dong MS; Yamazaki H; Guo Z; Guengerich FP
    Arch Biochem Biophys; 1996 Mar; 327(1):11-9. PubMed ID: 8615680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a human cytochrome P450 1A1: rat NADPH-cytochrome P450 reductase fusion protein cDNA and expression in Escherichia coli, purification, and catalytic properties of the enzyme in bacterial cells and after purification.
    Chun YJ; Shimada T; Guengerich FP
    Arch Biochem Biophys; 1996 Jun; 330(1):48-58. PubMed ID: 8651703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Search for cell culture systems with diverse xenobiotic-metabolizing activities and their use in toxicological studies.
    Glatt H; Gemperlein I; Turchi G; Heinritz H; Doehmer J; Oesch F
    Mol Toxicol; 1987-1988 Fall; 1(4):313-34. PubMed ID: 3151500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of functional human cytochrome P450 monooxygenase systems in Escherichia coli.
    Pritchard MP; McLaughlin L; Friedberg T
    Methods Mol Biol; 2006; 320():19-29. PubMed ID: 16719371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
    Roitel O; Scrutton NS; Munro AW
    Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of CYP3A9 gene expression by estrogen and catalytic studies using cytochrome P450 3A9 expressed in Escherichia coli.
    Wang H; Strobel HW
    Arch Biochem Biophys; 1997 Aug; 344(2):365-72. PubMed ID: 9264551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1.
    Shimada T; Hayes CL; Yamazaki H; Amin S; Hecht SS; Guengerich FP; Sutter TR
    Cancer Res; 1996 Jul; 56(13):2979-84. PubMed ID: 8674051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterologous expression of human drug-metabolizing enzymes.
    Guengerich FP; Parikh A; Johnson EF; Richardson TH; von Wachenfeldt C; Cosme J; Jung F; Strassburg CP; Manns MP; Tukey RH; Pritchard M; Fournel-Gigleux S; Burchell B
    Drug Metab Dispos; 1997 Nov; 25(11):1234-41. PubMed ID: 9351898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of promutagens catalyzed by Drosophila melanogaster CYP6A2 enzyme in Saccharomyces cerevisiae.
    Saner C; Weibel B; Wurgler FE; Sengstag C
    Environ Mol Mutagen; 1996; 27(1):46-58. PubMed ID: 8625948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of indigo by recombinant mammalian cytochrome P450.
    Gillam EM; Aguinaldo AM; Notley LM; Kim D; Mundkowski RG; Volkov AA; Arnold FH; Soucek P; DeVoss JJ; Guengerich FP
    Biochem Biophys Res Commun; 1999 Nov; 265(2):469-72. PubMed ID: 10558891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of modified cytochrome P450 2C10 (2C9) in Escherichia coli, purification, and reconstitution of catalytic activity.
    Sandhu P; Baba T; Guengerich FP
    Arch Biochem Biophys; 1993 Nov; 306(2):443-50. PubMed ID: 8215449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of procarcinogens by human cytochrome P450 enzymes expressed in Escherichia coli. Simplified bacterial systems for genotoxicity assays.
    Shimada T; Gillam EM; Sandhu P; Guo Z; Tukey RH; Guengerich FP
    Carcinogenesis; 1994 Nov; 15(11):2523-9. PubMed ID: 7955101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme.
    Gillam EM; Baba T; Kim BR; Ohmori S; Guengerich FP
    Arch Biochem Biophys; 1993 Aug; 305(1):123-31. PubMed ID: 8342945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
    Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
    Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of heterologously-expressed cytochrome P450 and glutathione transferase enzymes in toxicity assays.
    Guengerich FP; Wheeler JB; Chun YJ; Kim D; Shimada T; Aryal P; Oda Y; Gillam EM
    Toxicology; 2002 Dec; 181-182():261-4. PubMed ID: 12505322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.